Norway· NO-ID_7A227DC7-668F-4D5E-B9FF-4373CC40C186
Minjuvi
A tafasitamab product containing tafasitamab, registered in Norway by Incyte Biosciences Distribution B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Tafasitamab is registered in 13 of 19 countries.
Countries holding a registration under ATC L01FX12 (tafasitamab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Tafasitamab · ATC L01FX12
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tafasitamab costs, country by country.
Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tafasitamab · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$272.81
The record
At a glance
FEST (Norway)- Active substance
- Tafasitamab
- Manufacturer
- Incyte Biosciences Distribution B.V.
- Country
- Norway (NO)
- ATC code
- L01FX12
- ATC class
- Tafasitamab
- Defined daily dose
- 60 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_7A227DC7-668F-4D5E-B9FF-4373CC40C186
- no_varenummer121344200NOK 10792.7
- gtin7640159434122
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
58 interactions on record for tafasitamab.
Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tafasitamab · interactions on record
58 records
- 28 severe
- 30 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tafasitamab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandMINJUVIOrifarm Oy
- CzechiaMINJUVIIncyte Biosciences Distribution B.V., Amsterdam
- SpainMINJUVI 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONIncyte Biosciences Distribution B.V.
- United KingdomMinjuvi 200mg powder for concentrate for solution for infusion vialsIncyte Biosciences UK Ltd
- IrelandMINJUVI 200 mg powder for concentrate for solution for infusionIncyte Biosciences Distribution B.V.
- IcelandMinjuviIncyte Biosciences Distribution B.V.
- PolandMinjuviIncyte Biosciences Distribution B.V.
- BelgiumMinjuvi 200 mgIncyte Biosciences Distribution
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Minjuvi
- Liechtenstein · Minjuvi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/53e6a8d1-6df0-4b52-8229-327a8539212e GET /v1/drugs/53e6a8d1-6df0-4b52-8229-327a8539212e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Tafasitamab",
"merkevare_id": "ID_7A227DC7-668F-4D5E-B9FF-4373CC40C186",
"name_form_strength": "Minjuvi pulv til kons til inf væske, oppl 200 mg",
"prescription_group": "C"
}See everything about tafasitamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.